Articles of Science

News »

Second group of volunteers join Soberana clinical trials

Cartel vacuna

Twenty more Cubans joined the short history of Soberana 01, the country’s first candidate vaccine against COVID-19, on September 2, according to reports from Naturaleza Secreta. This group, composed of volunteers between 60 and 80 years of age, is the second to receive the first dose of the much awaited vaccine.

News »

Soberana in the first phase of clinical trials

Soberana vacuna

The first stage of clinical trials for the definitive validation of Soberana, the Cuban candidate vaccine authorized to begin this phase, began August 24, with the administration of the product to 20 volunteers, between the age of 19 and 59. Over the course of the week, the safety of the candidate vaccine was evaluated and the findings submitted to the Center for State Control of Medications (Cecmed)

News »

Soberana is Cuba’s, the first candidate vaccine against COVID-19 in Latin America and the Caribbean

Covid vacuna cartel

A vaccine that exemplifies the development of Cuban science; that places us on the level of economically advanced countries; that honors Comandante en Jefe Fidel Castro Ruz, the principal architect of the country’s biotechnology sector. This is what Soberana is, the first Cuban candidate vaccine against COVID-19 authorized for testing in clinical trials.

News »

Díaz-Canel meets with Cuban scientists working on COVID-19 candidate vaccines

canel artemisa

The President of the Republic, Miguel Díaz-Canel Bermúdez, recently held a discussion with a group of scientists working on the development of COVID-19 candidate vaccines, to contain the dangerous illness that has caused the deaths of more than 766,000 persons around the world, 88 in our nation.

News »

The Cuban pharmaceutical industry vs COVID-19

vacunas-rusia-covid-19- 300

The Cuban pharmaceutical industry has been key to the national strategy to confront the SARS-COV-2 pandemic, guaranteeing medications to implement treatment protocols established by the Ministry of Public Health (Minsap), including several products used successfully with high-risk segments of the population, reducing the number of patients reaching serious and critical conditions, as well as mortality rates for this group.

News »

BioFarma Innovations, a new joint enterprise created by BioCubaFarma and SG Innovations Limited

Cuba biofarma

The new partnership aims to provide broader access to BioCubaFarma’s patent-protected portfolio of biopharmaceutical products, developed by the pharmaceutical and biotechnology industry in Cuba. Cuba’s BioCubaFarma Enterprise Group and the British company SG Innovations Limited has announced the creation of a new company, BioFarma Innovations focused on accelerating the development of new medications and their distribution in Europe and the British Commonwealth.

News »

Cuban drug approved to treat COVID-19 in India

Cuba farmacos

India’s Drug Regulatory Authority has approved exceptional use of the Cuban drug Itolizumab to treat severe patients with COVID-19, reported Eduardo Ojito Magaz, director of Cuba’s Molecular Immunology Center (CIM), on Twitter. Winner of a National Prize from the Cuban Academy of Sciences in 2014, this humanized monoclonal antibody has been part of the medical care protocol for COVID-19 in Cuba since April.

News »

First 500 Cuban-made ventilators coming soon

Investigaciones covid

By October, the national health system should have on hand the first 500 ventilators built In Cuba, reported Dr. Mitchell Valdés Sosa, director of the Cuban Neuroscience Center (CNEURO), affiliated with the BioCubaFarma enterprise group. This figure includes 250 machines described as invasive, that is, the patient must be physically connected via intubation. These are used primarily in intensive care units to aid patients in serious and critical condition.

News »

Interferon in Cuba, a prophecy come true

heberon

When Comandante en Jefe Fidel Castro inaugurated the Center for Genetic Engineering and Biotechnology (CIGB) on July 1, 1986, he said he expected more from combinations of alpha and gamma interferons than from the individual use of the products, first produced in Cuba 39 years ago, on May 28, 1981. That prediction became a reality on August 4, 2016, when Heberferon, a new formulation of IFNS alpha and gamma interferons for the treatment of basal cell carcinoma.

News »

Fidel versus COVID-19 and beyond

Fidel covid

The fact that Cuba’s response to the COVID-19 has been far more effective than most countries in the region, including the United States and also several European nations, is a reality that is becoming evident. A health system based on prevention, with a presence in all communities of medical offices, organized by neighborhood and linked to polyclinics, as well as general and specialized hospitals.